PELLICANO', Giovanni Francesco
 Distribuzione geografica
Continente #
NA - Nord America 11.369
EU - Europa 11.230
AS - Asia 6.752
SA - Sud America 2.945
AF - Africa 198
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.514
Nazione #
US - Stati Uniti d'America 11.128
RU - Federazione Russa 3.659
SG - Singapore 3.072
BR - Brasile 2.605
IT - Italia 1.806
IE - Irlanda 1.783
CN - Cina 1.614
SE - Svezia 1.391
HK - Hong Kong 972
DE - Germania 575
PL - Polonia 547
VN - Vietnam 393
UA - Ucraina 359
FI - Finlandia 278
GB - Regno Unito 238
FR - Francia 222
AR - Argentina 129
IN - India 124
CA - Canada 105
AT - Austria 102
MX - Messico 85
BD - Bangladesh 74
TR - Turchia 72
IQ - Iraq 66
EC - Ecuador 65
ZA - Sudafrica 63
ID - Indonesia 57
NL - Olanda 49
BE - Belgio 46
MA - Marocco 42
UZ - Uzbekistan 41
ES - Italia 39
PK - Pakistan 38
VE - Venezuela 35
CO - Colombia 32
JP - Giappone 30
PY - Paraguay 22
CL - Cile 19
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 17
PE - Perù 17
AE - Emirati Arabi Uniti 16
LT - Lituania 16
AZ - Azerbaigian 15
JO - Giordania 15
KR - Corea 15
UY - Uruguay 15
AL - Albania 14
DZ - Algeria 12
KE - Kenya 12
LV - Lettonia 12
NP - Nepal 12
EG - Egitto 11
IR - Iran 11
TH - Thailandia 11
BG - Bulgaria 10
CH - Svizzera 10
DO - Repubblica Dominicana 10
JM - Giamaica 10
KG - Kirghizistan 10
PT - Portogallo 10
TN - Tunisia 10
AU - Australia 9
KZ - Kazakistan 9
MY - Malesia 9
EU - Europa 8
OM - Oman 8
RO - Romania 8
SN - Senegal 8
BH - Bahrain 7
HN - Honduras 7
PA - Panama 7
RS - Serbia 7
SA - Arabia Saudita 7
GE - Georgia 6
IL - Israele 6
LK - Sri Lanka 6
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
GR - Grecia 5
LB - Libano 5
NG - Nigeria 5
AM - Armenia 4
GH - Ghana 4
GT - Guatemala 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BF - Burkina Faso 3
BN - Brunei Darussalam 3
BW - Botswana 3
BY - Bielorussia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MK - Macedonia 3
PH - Filippine 3
PS - Palestinian Territory 3
TW - Taiwan 3
Totale 32.485
Città #
Moscow 1.906
Dublin 1.779
Dallas 1.622
Singapore 1.515
Chandler 1.402
Ashburn 1.189
Hong Kong 969
Jacksonville 875
Nyköping 764
Beijing 721
Warsaw 533
Princeton 431
Dearborn 416
Messina 375
Los Angeles 265
Des Moines 262
Medford 258
Ann Arbor 226
The Dalles 213
New York 201
São Paulo 192
Boardman 162
Cambridge 154
Munich 146
Buffalo 134
Redondo Beach 128
Ho Chi Minh City 112
Rome 111
Wilmington 98
Palermo 93
Jinan 89
Milan 87
Dong Ket 85
Rio de Janeiro 79
Hanoi 76
Helsinki 76
Nuremberg 73
Catania 70
San Mateo 65
Belo Horizonte 64
Tianjin 64
Houston 62
Woodbridge 60
Nanjing 54
Shenyang 54
Vienna 53
Lancaster 51
Turku 49
Brasília 48
Brussels 46
Curitiba 44
Bremen 42
Pune 42
Brooklyn 41
Santa Clara 40
Tashkent 38
Seattle 36
Johannesburg 35
Porto Alegre 35
Frankfurt am Main 32
Guangzhou 32
Montreal 32
Denver 30
Zhengzhou 30
Hebei 29
Jakarta 29
Ningbo 28
Chennai 27
Haikou 27
Atlanta 26
Campinas 26
Orem 26
Tokyo 26
Salvador 25
Stockholm 25
Caltagirone 24
Goiânia 24
Guarulhos 24
Guayaquil 24
Hangzhou 24
London 24
Mexico City 24
Norwalk 24
Ottawa 24
Ribeirão Preto 24
Toronto 24
Baghdad 23
Phoenix 23
San Francisco 23
Taizhou 23
Boston 22
Falls Church 22
Naples 21
Poplar 21
São José dos Campos 21
Ankara 20
Fairfield 20
Manchester 20
Nanchang 20
Redwood City 20
Totale 19.923
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 434
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 282
Wasting Syndrome (cachessia da HIV) in paziente confetto HBV-HCV 256
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 248
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 235
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 219
Breast cancer in women living with HIV 201
AIDS E SISTEMA NERVOSO CENTRALE NEL PAZIENTE ADVANCED-NAÏVE 180
SINDROME INFIAMMATORIA DA IMMUNORICOSTITUZIONE (IRIS) 178
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 177
La terapia della brucellosi cronica con ciprofloxacina. Esperienze personali 168
Bioenergetics of T Cell Activation and Death in HIV Type 1 Infection 168
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 166
Sindrome Retrovirale Acuta (SRA) in giovane omosessuale maschio 165
Evaluation of HIV transmission cluster among natives and foreigners living Italy 164
QUANTO I GIOVANI DELLA CITTA’ DI MESSINA CONOSCONO L’HIV/AIDS E LE MALATTIE SESSUALMENTE TRASMESSE? 160
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 157
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 156
Alterazioni della membrana plasmatica in linfociti del sangue periferico di soggetti affetti da infezione da HIV/AIDS 150
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 149
Anxiety disorders and adherence to HAART 148
Danno ipossico in linfociti T periferici di soggetti affetti da HIV/AIDS. 148
Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report 148
La vaccinazione del soggetto HIV+: l’esperienza di una Azienda Ospedaliera Universitaria del Sud Italia 147
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 147
Aspetti clinico-epidemiologici della spondilodiscite brucellare 145
Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytesThe HIV-induced cell cycle dysregulation revisited 143
An evaluation of the burden of invasive Enterococcal infection in a large university hospital 143
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 143
DANNO IPOSSICO IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+: RUOLO DELLA FIBROSI LINFONODALE. 142
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 142
Bone disease in HIV infection: an overview of pathogenesis, clinical manifestations and treatment 142
APPLICAZIONI INNOVATIVE PER LA DIAGNOSTICA DELL'INFEZIONE DA HIV 141
Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students 141
48 Week efficacy of first line antiretroviral treatments for hiv infection in 1998 and 2006: preliminary results of a multicentric investigation 138
A proposito di una osservazione di sindrome di Loffler in corso di ascaridiasi 138
Neurotoxoplasmosi in soggetto HIV positivo “advanced naive”. Segnalazione di caso clinico 137
Assistenza alla persona con HIV/AIDS 137
Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs 136
DISFUNZIONE MITOCONDRIALE IN LINFOCITI T CIRCOLANTI DI PAZIENTI HIV+. 136
19. Nostre esperienze con ciprofloxacina nella terapia della brucellosi acuta 135
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 135
DANNO IPOSSICO IN LINFOCITI T PERIFERICI DI SOGGETTI AFFETTI DA HIV/AIDS. 133
ASSISTENZA ALLA PERSONA CON DISTURBI IMMUNO-MEDIATI 133
Malignant melanoma in HIV: epidemiology, pathogenesis and management 133
Prostate cancer in HIV-positive patients: a review of the literature 132
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 132
Nuovi regimi di terapia: l’utilizzo rationale di nuovi farmaci e nuove strategie (regimi nuk-sparing) 131
Nucleolin relocalization associated top re-lethal alterations of T cell morphology: redefining death in HIV infection 131
Acute pericarditis during early-diagnosed Brucellosis: a case report. 131
Kaposi’s Sarcoma and Psoriasis in a naïve HIV-positive patient: a case report 131
MASSIVA MORTE APOPTOTICA DI LINFOCITI T NEL SANGUE PERIFERICO DI SOGGETTI INFETTI DA HIV: CONSEGUENZE PATOLOGICO-CLINICHE 130
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 129
La terza età della terapia antiretrovirale di combinazione 129
HIV and Colorectal Cancer. New Insights and Review of the Literature 129
Real-life efficacy and satisfaction of long-acting ART CabotegravirRilpivirine in HIV-infected individuals 127
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 126
A proposito della immunoterapia attiva nella Brucellosi Cronica 126
FARMACORESISTENZE E LORO CORRELAZIONI IN PAZIENTI HIV-1+ 125
Bone marrow biopsy findings in brucellosis patients with hematologic abnormalities: useful remarks. 125
IL TENOFOVIR NELLA TERAPIA ANTIRETROVIRALE: OSSERVAZIONI SULLA POSSIBILE NEFROTOSSICITA' DEL FARMACO 123
HCV elimination in persons living with HIV (PLWH): the NoCo (No Coinfection) study of the ICONA network 121
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+ 120
96 Week Follow-Up of HIV-Infected Patients in Rescuewith Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience 119
Encefalopatia latente in corso di cirrosi alcoolica 118
Transmission mode associated with coronavirus disease 2019: a review 118
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 118
FARMACOGENETICA NELLA PRATICA CLINICA IN UNA POPOLAZIONE SICILIANA HIV+ 117
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 117
Pseudomonas aeruginosa detection in South Italy: an epidemiological survey 117
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 117
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 117
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 117
AIDS Dementia Complex in paziente Advanced Naïve 116
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 116
Massiva morte apoptotica di linfociti T nel sangue periferico di soggetti infetti da HIV: conseguenze patologico-cliniche 115
Treatment of chronic brucellosis with ciprofloxacin. Personal experience 114
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 114
Epidemiology of Klebsiella pneumoniae MDR during the years 2015-2017 in “G. Martino” University Hospital of Messina: preliminary data. 113
1605. Dual Therapy VS Triple Therapy in Experienced PLWH: a Multicentre One-Year Long Observational Study 112
CASO CLINICO: PAZIENTE HIV/HCV e “INDULTO” 112
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 112
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 112
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 112
Analisis of efficacy and tolerability of raltegravir based regimens by background therapy in salvage: a Mulcicentre Italian Experience. 111
La patologia intestinale e ruolo di Giardia Lamblia in soggetti HIV+. 110
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 110
Current fast methods for the identification of carbapenemase enzymes in clinical laboratory. 110
Comparative neuropsychiatric toxicity profile of dolutegravir (DGT)-based versus efavirenz (EFV)-based versus other recommend first-line antiretroviral therapies (ART): data from ICONA Foundation Study Cohort. 110
HIV and Mediterranean Zoonoses: A Review of the Literature 108
RUOLO DELLA TRANSGLUTAMINASI 2 NELL’INFEZIONE DA HIV. 108
EDITORIAL – IMPROVING ACCESS AND ADHERENCE TO SCREENING TESTS FOR CANCERS: A NEW, THOUGH OLD, CHALLENGE IN THE HIV EPIDEMICS 106
Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre italian study. 106
New and old assumptions of lung cancer in people living with HIV 106
Farmacogenetica: Un buon ausilio per il paziente e per il clinico 105
Factors Associated With Weight Gain in People Treated With Dolutegravir 105
A proposito di un caso di meningoencefalite da 1isteria monocitogenes 104
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 104
Health status and Quality of life in people living with HIV (PLWH): results from the ICONA cohort 104
HPV AND URINARY BLADDER CARCINOMA: A REVIEW OF THE LITERATURE 103
Totale 13.955
Categoria #
all - tutte 117.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.132 0 0 0 0 0 217 138 174 126 196 114 167
2021/20222.177 21 222 44 104 145 42 101 106 54 209 257 872
2022/20235.806 780 394 225 471 425 565 116 329 2.182 39 203 77
2023/20241.483 149 202 121 172 96 290 39 72 24 69 51 198
2024/20257.757 112 106 165 479 631 191 187 1.599 1.989 437 617 1.244
2025/202610.766 851 1.425 1.762 1.347 1.432 3.949 0 0 0 0 0 0
Totale 34.079